Cargando…

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience

OBJECTIVE: To evaluate the response to cabergoline (CBG) treatment in patients with non-functioning pituitary adenomas (NFPA). SUBJECTS AND METHODS: Retrospective, single tertiary care center study. A total of 44 patients were treated with 3 mg/week of CBG, 32 after surgical treatment (transsphenoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vargas-Ortega, Guadalupe, González-Virla, Baldomero, Balcázar-Hernández, Lourdes, Arreola-Rosales, Rocío, Benitez-Rodríguez, Francisco Javier, Félix, Blas López, Mercado, Moisés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697635/ https://www.ncbi.nlm.nih.gov/pubmed/35758837 http://dx.doi.org/10.20945/2359-3997000000495

Ejemplares similares

An FSH and TSH pituitary adenoma, presenting with precocious puberty and central hyperthyroidism
por: Vargas, Guadalupe, et al.
Publicado: (2017)

Parathyroid Crisis as Presentation of Atypical Parathyroid Adenoma: Two Diagnostically Challenging Cases
por: Landeta, Galo Andrés Salvador, et al.
Publicado: (2022)

Cardiovascular Risk and Metabolic Syndrome Characteristics in Patients with Nonfunctional Pituitary Macroadenoma
por: Vargas-Ortega, Guadalupe, et al.
Publicado: (2018)

The Testosterone Effect on Metabolic and Urologic Outcomes in Patients with Nonfunctioning Pituitary Macroadenomas and Hypogonadotropic Hypogonadism
por: Vargas-Ortega, Guadalupe, et al.
Publicado: (2019)

Pituitary Abscess: A General Retrospective Diagnosis
por: Tenorio Hernández, Ixchel Maydee, et al.
Publicado: (2023)

Anorexia–cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma
por: Balcázar-Hernández, Lourdes, et al.
Publicado: (2017)

Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
por: Saand, Aisha R, et al.
Publicado: (2021)

Treatment of Postsurgical Clinically Nonfunctioning Pituitary Adenomas Remnants With Cabergoline
por: Vieira, Marina C M, et al.
Publicado: (2021)

Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer
por: Vargas-Ortega, Guadalupe, et al.
Publicado: (2018)

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
por: Bozkirli, Emre, et al.
Publicado: (2013)

NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas
por: Jian, Fangfang, et al.
Publicado: (2021)

Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
por: Vargas, Guadalupe, et al.
Publicado: (2015)

Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas
por: Wu, Zerui, et al.
Publicado: (2021)

Hypothalamic-pituitary-gonadal axis disturbance and its association with insulin resistance in kidney transplant recipients
por: Balcázar-Hernández, Lourdes, et al.
Publicado: (2022)

PMON170 Treating human primary non-functioning pituitary adenoma cells with cabergoline
por: Begalli, Federica, et al.
Publicado: (2022)

Biochemical Characteristics of Bone Mineral Metabolism before and throughout the First Year after Kidney Transplantation, Persistent Hyperparathyroidism, and Risk Factors in a Latin Population
por: Balcázar-Hernández, Lourdes, et al.
Publicado: (2020)

The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages
por: Taniguchi-Ponciano, Keiko, et al.
Publicado: (2022)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors
por: Taniguchi-Ponciano, Keiko, et al.
Publicado: (2020)

Severity of Fatigue and Its Relationship with TSH before and after Levothyroxine Replacement Therapy in Patients with Primary Hypothyroidism
por: Ruíz-Pacheco, María Guadalupe, et al.
Publicado: (2023)

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
por: Ceccato, Filippo, et al.
Publicado: (2021)

Delayed Calcium Normalization after Successful Parathyroidectomy in Primary Hyperparathyroidism
por: de la Cruz Rodríguez, Iván Emilio, et al.
Publicado: (2021)

Efficiency and Safety of CyberKnife Robotic Radiosurgery in the Multimodal Management of Patients with Acromegaly
por: Romero-Gameros, Carlos Alfonso, et al.
Publicado: (2023)

Cabergoline-induced Mania in a Patient of Pituitary Microadenoma
por: Mohapatra, Satyakam, et al.
Publicado: (2017)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages
por: Taniguchi-Ponciano, Keiko, et al.
Publicado: (2020)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
por: Singh, Pratibha, et al.
Publicado: (2011)

SAT-272 Pituitary Macroadenoma Co-Secreting TSH and PRL Responsive to Cabergoline
por: Tirumalasetty, Saritha, et al.
Publicado: (2020)

Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline
por: Walia, Rama, et al.
Publicado: (2011)

SAT-246 A Case of Cabergoline Induced Pituitary Apoplexy in a Patient with Prolactinoma
por: Ahuja, Ashim
Publicado: (2020)

Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature
por: Ramírez, Claudia, et al.
Publicado: (2013)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report
por: Lin, Shaojian, et al.
Publicado: (2022)

Cytology of Pituitary Adenomas
por: Doniach, I.
Publicado: (1972)

The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019)

The Genetics of Pituitary Adenomas
por: Tatsi, Christina, et al.
Publicado: (2019)

The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
por: Kim, Jee Soon, et al.
Publicado: (2016)

Risk Factors Associated with Mortality among Patients with COVID-19: Analysis of a Cohort of 1213 Patients in a Tertiary Healthcare Center
por: Romero-Gameros, Carlos Alfonso, et al.
Publicado: (2022)

Remission in Cushing disease with cabergoline
por: Gopal, Raju, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kperendjk7iu97bago9tn35r3a